IMMUTEP ADR WKN: A2H8YL ISIN: US45257L1089 Kürzel: IMMP Forum: Aktien Thema: Hauptdiskussion

https://www.globenewswire.com/news-release/2020/09/18/2095593/0/en/Immutep-Announces-Improving-Results-from-Stage-I-of-Phase-II-TACTI-002-Study.html

Hier entwickelt sich was

Was ist den heute los?

Ich warte schon

Rakete startet 🚀

https://www.immutep.com/files/content/investor/analyst-report/2020/20200514-Goetzpartners-First%20in%20class%20opening%20the%20cancer%20immune%20throttle.pdf

https://www.immutep.com/files/content/investor/press-release/2019/2039429.pdf

WuXi Biologics Congratulates Immutep on Positive Interim Data for IMP-321 https://seekingalpha.com/pr/17787266?source=ansh $IMMP, $WXXWY

Immutep’s study has reportedly recorded that 47% of 1st line non-small cell lung cancer patients and 33% of 2nd line head and neck squamous cell carcinoma patients, reported encouraging responses. https://smallcaps.com.au/immutep-reports-positive-data-ongoing-trial-cancer-drug-efti/

http://stocktwits.com/tkathlina/message/195448127

Morgen wird es nochmal interessant

Dann im März Daten der größeren Studie.

Ich denke krebskongress in Berlin ist hier das nächste Ziel.

Immutep Activities Report    January 29, 2020 08:00 ET | Source: Immutep Limited First progression-free survival (“PFS”) data expected from late-stage Phase IIb metastatic breast cancer study, AIPAC, in March 2020 More mature data expected from TACTI-002 in February 2020 Sufficiently funded to deliver key upcoming catalysts http://www.globenewswire.com/news-release/2020/01/29/1976732/0/en/Immutep-Activities-Report.html

http://stocktwits.com/tripleface/message/191113215

Zu viert! 😉 Da ist ordentlich was in der Pipeline bei Immutep!